Related by context. All words. (Click for frequent words.) 81 Oral Presentation 77 Poster Discussion 76 Poster Session 75 Late Breaker 73 Poster Presentation # 72 Poster Presentations 72 Abstract Number 72 Oral Session 70 Clinical Trial Results 70 Oral Fingolimod 69 Selective Cardiac Myosin 69 Inflammatory Arthritis 68 Suppl. 68 Oral Presentations 68 Relapsing Multiple Sclerosis 68 Clinical Trials Update 68 J Clin Oncol 67 Dendritic Cells 67 J Virol 67 Vitro Activity 66 FASEB J. 66 J Clin Endocrinol Metab 66 Annual ICAAC 66 Thromb Haemost 66 Arch Neurol 66 Therapeutic Targets 66 EMBO J. 66 J Clin 66 Abstract # 65 Antiviral Therapy 65 Immunogenicity 65 Biological Therapy 65 Ann Rheum Dis 65 Multicenter Study 65 Cancer Res 65 abstr 65 Crit Rev 65 J Pediatr 65 Room #AB [002] 65 Cochrane Database Syst Rev. 65 Podium Presentation 65 Nicotine Vaccine 65 ISPOR 65 Preclinical Data 65 Br J Cancer 65 LENALIDOMIDE 65 Environ Health Perspect 65 Solid Tumors 65 Nephrol 65 Neurol 65 Safety Tolerability 65 See CLINICAL PHARMACOLOGY 65 J Nutr 65 Autoimmunity 65 Ann Oncol 65 Am J Epidemiol 65 Prolongs Survival 64 Hematol 64 Double Blind Placebo 64 SABCS 64 J Allergy Clin 64 Pharmacodynamics 64 Clinical Outcome 64 #:#-# [035] 64 Gastrointestinal Cancers Symposium 64 Placebo Controlled Study 64 Free Full Text 64 Int J Cancer 64 Novel Therapeutics 64 Kinase Inhibitor 64 HCV Protease Inhibitor 64 Clin Oncol 64 Chicago Multidisciplinary Symposium 64 BIOCOM Investor Conference 64 ASH Annual Meeting 64 Obstet Gynecol 64 Study Evaluating 64 Novel Inhibitor 64 Mammalian Cells 64 Randomized Controlled Trials 64 #:#-# [001] 64 Meta Analysis 64 Eur J 64 Molecular Basis 64 J Affect Disord 64 Nat Clin Pract 64 Phase Ib Clinical Trial 64 #:#-# [023] 64 Phase 2a Trial 64 Small Molecule 63 Dose Ranging Study 63 #nd Annual Meeting 63 Anti Tumor Activity 63 Pooled Analysis 63 Preclinical Evaluation 63 Anticancer Drugs 63 J Natl Cancer Inst 63 ASCO GI 63 #nd EORTC NCI 63 Preclinical Study 63 Orthop Surg 63 AACR #st Annual Meeting 63 DOI #.#/hep.# 63 Anticancer Drug 63 ICAAC IDSA 63 Presents Preclinical Data 63 Novel Antibiotic 63 Endocrinol 63 Orally Active 63 II Clinical Trial 63 AASLD Meeting 63 Diabet Med 63 #:#-# [031] 63 Scientific Poster Session 63 Mouse Model 63 Ophthalmol 63 #st Annual Meeting 63 J Child Adolesc 63 Curr Opin 63 Oncol 63 Eur J Cancer 63 AACR IASLC Joint 63 Dose Escalation 63 Randomized Phase 63 Clinical Efficacy 63 #:#-# [029] 63 Differential Diagnosis 63 Novel Therapeutic 63 UEGW 63 #-# Full Text 63 Proc Am Soc 63 Randomized Clinical Trials 63 Br J Psychiatry 63 J Am Soc 63 Hematological Malignancies 63 Anti Tumor 63 Psychopharmacol 63 Arthritis Rheum 63 Antiviral Activity 63 Treating Chronic 63 Neurosurg 63 Br J Haematol 63 Phase IIb Clinical Trial 63 J Rheumatol 63 Tumor Biology 63 EORTC NCI AACR 62 Cancer Immunotherapy 62 Malignant Lymphoma 62 Double Blind Randomized 62 Placebo Controlled Trial 62 J Neurol 62 Antigen Specific 62 Clinical Evaluation 62 Recombinant Human 62 Prenatal Diagnosis 62 Chronic Lymphocytic Leukemia 62 ECCMID 62 AAEP Convention 62 Phase 2b Clinical Trial 62 J Urol 62 Chronic Hepatitis C 62 Controlled Trial 62 Psychiatric Services #:#-#,# 62 Osteoporosis Treatment 62 Suppl 62 IND Application 62 Biol Phys 62 #:#-# [006] 62 Oral Abstract 62 Hsp# Inhibitor 62 Castration Resistant Prostate Cancer 62 Vaccine Adjuvant 62 CROI 62 Monoclonal Antibodies 62 #:#-# [019] 62 Immunol 62 #:# -# [004] 62 Pathol 62 AACR Meeting 62 Pharmacokinetics PK 62 #:#-# [025] 62 Chronic Hepatitis B 62 Hepatocellular Carcinoma 62 Pediatr 62 Cochrane Database Syst Rev 62 Randomized Double Blind Placebo 62 Rheumatol 62 ASCO GU 62 Developmental Therapeutics Immunotherapy 62 Adjunctive Therapy 62 Biol 62 Neoplasia 62 Am J Gastroenterol 62 Mouse Models 62 #th Interscience Conference 62 Innate Immunity 62 Seasonal Influenza Vaccine 62 RNAi Therapeutic 62 Prostate Cancer Symposium 62 Novel Approaches 62 Pharmacokinetics 62 #:#-# [040] 62 Malignancies 62 Treatment Regimens 62 Ann Intern Med 62 Urinary Incontinence 62 Protease Inhibitor 62 VOICE OF THE READER 62 AACR San Antonio 62 Randomized Double blind 62 Obes Res 62 Nat Genet 62 #:#-# [020] 62 Selective Cardiac Myosin Activator 62 Oligonucleotides 61 J Appl 61 Ann Emerg Med 61 Antiretroviral Agents 61 Anesth 61 Metastatic Melanoma 61 J Am Acad 61 Toxicol 61 Drug Candidate 61 Psychopharmacol Bull 61 Parathyroid Hormone 61 Novel Oral 61 Advanced Solid Tumors 61 Clinical Trial Data 61 Molecular Mechanisms 61 Phase 2b Trial 61 Hemodialysis Patients 61 Treated Patients 61 Proc Natl Acad Sci 61 Genitourinary Cancers Symposium 61 J Clin Psychopharmacol 61 Biol Psychiatry 61 Int J Epidemiol 61 Previously Treated 61 Autoimmune Diseases 61 Present Preclinical Data 61 Postdoctoral Position 61 Immune Responses 61 Rotavirus Vaccine 61 #:#-#,# [003] 61 Physiology Seminar 61 Inflammatory Diseases 61 Fast Skeletal Troponin 61 Anticancer Activity 61 Aptamer 61 Arch Intern Med 61 Arch Dermatol 61 Dermatol 61 Female Urology 61 Fungal Infections 61 #:#-# [033] 61 Endocrine Society Annual Meeting 61 ANN INTERN MED 61 Antithrombotic 61 J Clin Psychiatry 61 Mol Psychiatry 61 Activator CK # 61 nd Annual Meeting 61 Phase 2a Clinical Trial 61 J Consult Clin 61 Molecular Targets 61 Tyrosine Kinase Inhibitor 61 #:# -# [005] 61 Systemic Sclerosis 61 Oral Presentation # 61 Psychiatry Clin Neurosci 61 Emerging Therapies 61 Psychol 61 Therapeutic Approaches 61 Controlled Study 61 #:#-# [037] 61 Randomized Controlled 61 Investigational Drug 61 Clinical Practice Guideline 61 Breast Cancer Symposium 61 ERA EDTA 61 Kinase Inhibitors 61 Gynecol Oncol 61 Severe Sepsis 61 Epidemiol 61 SA FC# 61 Clin Pharmacol Ther 61 Kidney Int 61 Acta Paediatr 61 Pharmacyclics Announces 61 NEWSWATCH UPDATE 61 AACR NCI EORTC 61 ECNP 61 Breast Carcinoma 61 Cell Transplant 61 Targeted Therapies 61 Potent Antiviral Activity 61 MorphoSys AG FSE MOR 61 Polymorphism 61 Influenza Vaccines 61 Telbivudine 61 Single Dose 61 Fertil Steril 61 Recombinant Protein 61 Randomized Double Blind 61 #:# -# [006] 61 By Jennifer Micale 61 Completes Patient Enrollment 61 J Nerv Ment Dis 61 Beneficial Effects 61 Effectively Treats 61 Preclinical Studies 60 Novel Method 60 CD# [004] 60 Preclinical Models 60 Antitumor Activity 60 EFNS 60 #:# -# [001] 60 Photochemistry 60 Arch Pediatr Adolesc Med 60 Initiated Phase 60 Eur Respir J 60 J Exp Med 60 • lruane@news-press.com • 60 suppl. 60 Subtypes 60 Sports Exerc 60 Soc Sci Med 60 RNAi Therapeutics 60 #:#-# [030] 60 Interv 60 Adjuvant Chemotherapy 60 Antitumor 60 Epub ahead 60 Newly Diagnosed 60 Migraine Drug 60 Respiratory Viruses 60 Plaque Psoriasis 60 By Brenna Hillier 60 Ocular Diseases 60 Pharmacother 60 Disease Modifying 60 BIO InvestorForum 60 Reception #:#-# 60 Immunomedics Announces 60 Nephrol Dial Transplant 60 transthyretin TTR mediated amyloidosis 60 Stent Thrombosis 60 Oncologic 60 Receives Orphan Drug Designation 60 Nucleic Acids Res 60 ASCO Annual Meeting 60 Pathophysiology 60 Drug Formulation 60 Initiates Clinical Trial 60 Proves Effective 60 antibody blinatumomab MT#/MEDI-# 60 Protein Involved 60 Phase III Clinical Trial 60 Meets Primary Endpoint 60 Schizophr Bull 60 JAK2 Inhibitor 60 Molecular Origins 60 Abstract Free Full Text 60 Am Fam Physician 60 Therapeutics TCT scientific 60 Arch Dis Child 60 Crit Care Med 60 First Patient Dosed 60 J Biol Chem 60 Pract 60 Biologic Therapy 60 J Neurosurg 60 Randomized Study 60 Annu Rev 60 Anticoagulant 60 Nat Med 60 Arch Facial Plast 60 Gram Positive 60 Neuroendocrine Tumors 60 HER2 Positive 60 Int Clin Psychopharmacol 60 Combination REOLYSIN R 60 Shows Efficacy 60 Arch Gen Psychiatry 60 Tumor Microenvironment 60 By Toby McCasker 60 Adefovir 60 Myelodysplastic Syndromes 60 Abstract Full Text 60 Announcement acc 60 Protein Synthesis 60 Slow Progression 60 Kidney Transplant Patients 60 Therapeutic Vaccine 60 PMID # [002] 60 doi #.#/j.#-#.#.#.x 60 Canaccord Adams Hepatitis C 60 Am J Geriatr 60 Presents Positive 60 Urol 60 Child Adolesc Psychiatry 60 Am J Pathol 60 Immunomodulatory 60 Systematic Review 60 Cardiovasc 60 REG2 60 Improve Survival 60 #:#-# [002] 60 Clostridium difficile Infection 60 Int J Radiat Oncol 60 David Bodian Seminar 60 Newly Diagnosed Multiple Myeloma 60 #S #S [002] 60 entitled Synergistic 60 Clin Infect Dis 60 Files IND 59 Cardiovascular Risk Factors 59 Endocrinol Metab 59 Viral Infections 59 By Robbie Daw 59 Tumor Progression 59 Dividend Payout Changes 59 Survival Benefit 59 CorrespondentPosted 59 PM HKT 59 Pathogenesis 59 CrossRef Medline 59 Clin Endocrinol 59 Critically Ill Patients 59 Adjuvant Treatment 59 Appears Safe 59 Demonstrates Sustained 59 Histone Deacetylase 59 doi #.# 59 J Am Coll 59 Small Molecule Drug 59 Therapeutics TCT 59 Respiratory Infection 59 Therapeutic Vaccines 59 Clin J 59 Inflammatory Disease 59 Psychiatry Res 59 Related Disorders ICAD 59 Investigational Compound 59 Complicated Skin 59 Clinical Trial Evaluating 59 Vaccine Adjuvants 59 Tigecycline 59 Int J 59 Cogn 59 Rheumatoid Arthritis Patients 59 Neoadjuvant Chemotherapy 59 #:#-# [018] 59 AACR symposium 59 Neurosci 59 Soft Tissue Sarcoma 59 Bone Metastases 59 Antiepileptic Drugs 59 Mol Cell 59 Laryngeal Cancer 59 Systemic Delivery 59 Annual Transcatheter Cardiovascular 59 Am J Clin 59 Patients Treated With 59 Liver Metastases 59 Scand J 59 Novel Treatments 59 Comorbidities 59 Protein Kinase 59 Synthetic Peptide 59 IN PATIENTS WITH 59 Phys Ther 59 By Jacob Laxen 59 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 59 Ion Channels 59 Announces Poster Presentations 59 Collaborators Present 59 Gene Silencing 59 Prospective Multicenter 59 Randomised Controlled Trial 59 Subgroup Analysis 59 Eur Urol 59 Am Soc Nephrol 59 Tumor Angiogenesis 59 simpson @ 59 Coronary Revascularization 59 • dcastell@visalia.gannett.com • 59 Postmenopausal Women 59 Demonstrates Significant 59 Autoimmune Disease 59 Androgen Receptor 59 ASCO Abstract 59 Tablet Formulation 59 Statin Therapy 59 Immunotherapeutic 59 Bortezomib 59 Renal Cell Carcinoma 59 Gastrointestinal Cancer 59 Renal Cancer 59 Molecular Medicine Tri 59 Eur Arch 59 #:#:# AM PST 59 J Shoulder Elbow 59 Genetic Variation 59 Lancet Oncol 59 J Clin Invest 59 Radiol 59 Clin Orthop 59 Tezampanel 59 PDUFA Date 59 Modulates 59 Initiate Phase 59 J Cataract Refract 59 Fondaparinux 59 Treatment Naive Patients 59 Multicenter Phase 59 Nuvelo Announces 59 Sleep Disturbances 59 Phase IIa Clinical Trial 59 Cynthia Dizikes Published 59 Metastatic Renal Cell Carcinoma 59 Reports Preclinical Data 59 Biotechnol 59 Multiple Myeloma Patients 59 Well Tolerated 59 Cancer Incidence Mortality 59 Pulmonary Arterial Hypertension 59 Engl J Med 59 Hematological 59 Secondary Hyperparathyroidism 59 Retrovirus 59 EADV 59 Metabolic Disorders 59 Advanced Colorectal Cancer 59 e# [005] 59 Hematology Meeting 59 Randomized Phase III 59 Demonstrates Positive 59 Therapeutics Roundtable 59 Nat Rev 59 Romiplostim 59 b3c newswire 59 Diabetic Nephropathy 59 Novel Small Molecule 59 Novel Therapies 59 Hormone Refractory Prostate Cancer 59 Treatment Experienced 59 IND Filing 59 Guidelines Recommend 59 Chemokine Receptor 59 #:#-# [014] 59 Crit Care 59 Unresectable 59 Brain Metastases 59 Venous Thromboembolism 59 #:#-# [007] 59 Sangamo BioSciences Announces 59 QUICK TAKE FOR 59 J Foot Ankle 59 JOSEPH SAPIA • 59 Best Pract Res 59 Migraine Treatment 59 Combination Treatment 59 Oritavancin 59 Febuxostat 59 ASM Biodefense 59 Room #B 59 Drug Shows Promise 59 J Infect Dis 59 Lung Cancer Trial 59 room #AB 59 Reception #:#-#:# 59 See BioWorld Today 59 Shows Promising 59 Biomarker Study 59 Thrombolytic Therapy 59 Shows Promise Against 59 Cytotoxicity 59 Bioorganic 59 Prospective Randomized 59 Breast Ultrasound 59 Infect Dis 59 ENDO 59 #:#-#,# [002] 59 Newly Diagnosed Patients 59 Casey Selix Published 58 Vaccine Immunology 58 Maisie McCabe 58 Cardiotoxicity 58 Society CTOS 58 Demonstrates Efficacy 58 Chronic Myeloid Leukemia 58 BY Addy Dugdale 58 Autologous Stem Cell Transplantation 58 Molecular Mechanism 58 J Neurol Neurosurg Psychiatry 58 David Brauer Published 58 HCV Genotype 58 Infected Patients 58 Intravenous Formulation 58 Occup 58 Demonstrates Potent 58 Drug Combo 58 Atomoxetine 58 Int J Obes Relat 58 AACR #nd Annual Meeting 58 Transdermal Patch 58 Physiol 58 J Gerontol 58 BY ROB DEMOVSKY 58 CHRONICLE CORRESPONDENT published 58 Eur Heart 58 Novel Mechanism 58 Acute Ischemic Stroke 58 Decitabine 58 Tumor Response 58 Submits NDA 58 Protein Expression 58 Gastric Cancer 58 Microbiol 58 ICAAC 58 • community@dmreg.com • 58 Pharmacokinetic Study 58 BY LAURA RUANE 58 ASCO Breast Cancer 58 Metastatic Prostate Cancer 58 PMID # [001] 58 PhD DSc 58 EORTC NCI 58 Eur Respir J. 58 Therapeutic Potential 58 Elderly Patients 58 Demonstrate Significant 58 SYN# 58 Patients Receiving 58 EULAR Annual 58 Derek Wallbank Published 58 Oral Cavity 58 Phase III Trial 58 Phase IIb Trial 58 Breaking Clinical Trials 58 Spectrum Pharmaceuticals Announces 58 By Theo Valich 58 Pharmacodynamic 58 BY PAUL SRUBAS 58 Respiratory Virus 58 Adjuvant Therapy 58 Randomized Comparison 58 CNS Disorders 58 Carotid Endarterectomy 58 » Jillian Lebeck 58 Immune Mediated 58 Neuropathic Pain 58 Clin Chem 58 Polymerase Inhibitor 58 Cancer Stem Cells 58 Randomized Trials 58 Hematologic Malignancies 58 BiTE Antibody 58 Inflammatory Markers 58 Lupus Drug 58 AT APPROXIMATELY 58 Long Term Efficacy 58 Treatment Regimen 58 pralatrexate injection folate analogue 58 Gastroenterol 58 Eur J Neurol 58 journal Antimicrobial Agents 58 FDA APPROVES 58 HDAC Inhibitor 58 Ann Surg 58 Arch Surg 58 JAK Inhibitor 58 Peer Reviewed Journal 58 Genome Res 58 Genes Involved 58 Nuclear Receptors 58 Br J Dermatol 58 Biological Effects 58 S1 S# [002] 58 By Ebenezer Afanyi 58 familial amyloidotic polyneuropathy FAP 58 Kidney Function 58 Severe Asthma 58 Percutaneous Tibial Nerve Stimulation 58 Smooth Muscle 58 Mary Lahammer Published 58 General Psychiatry #:#-#,# 58 doi #.#/S#-# 58 Insulin Therapy 58 Belimumab 58 Schizophrenia Treatment 58 JAMA #:#-# 58 Patient Enrolment 58 NATION CorrespondentPosted 58 Content Outline 58 st Annual Meeting 58 Liposomal 58 Mol Biol 58 Hematology Annual Meeting 58 suppl 58 Immune Cell 58 #:#-#,# CrossRef Medline [002] 58 Abstract Accepted 58 LOS ANGELES MARITIME MUSEUM 58 Psychiatr Serv 58 Cancer iSBTc 58 Prospective Randomized Trial 58 Psychiatr 58 Multicenter Trial 58 Cognitive Function 58 Cardiol 58 By Melody Brumble 58 Progenitor Cells 58 TARRYTOWN NY BUSINESS WIRE 58 Mimetics 58 #:#-# [010] 58 Sirolimus Eluting Stent 58 RECORD1 58 EM BS 58 Webcast Scheduled 58 Refractory Angina 58 Diagnostic Criteria 58 Gene Linked 58 mlagesch@dmreg.com 58 Treatment Naïve 58 Observational Studies 58 Neural Stem Cells 58 Early Psychosis 58 Antiplatelet 58 Preclinical Efficacy 58 Pivotal Phase III 58 Neuropharmacology 58 Arterial Disease 58 Ranolazine 58 HMQ MT 58 Therapy Improves 58 Forodesine 58 Integrase Inhibitor 58 Plenary Session 58 lexidronam injection 58 Emerg Infect Dis 58 Trodusquemine MSI 58 Anti Angiogenic 58 Linezolid 58 Cancer Vaccines 58 DOI #.#/science.# 58 Submission Deadline 58 CALL FOR ENTRIES 58 J Psychopharmacol 58 Expert Opin 58 Preclinical Testing 58 ROBB Posted 58 Molecular Biomarkers 58 Capsules CII 58 Uterine Fibroid Embolization 58 Topline Results 58 Glenna Herald 58 CTRC AACR San Antonio 58 Molecular Diagnostic Test 58 BioCentury Future Leaders 58 Anthrax Toxin 58 PROSTASCINT R 58 Completes Enrollment 57 Improves Survival 57 Relapsed Multiple Myeloma 57 Bipolar Disorders 57 Tumor Suppressor Gene 57 Br J 57 Granted Orphan Drug 57 Biopharmaceutical Manufacturing 57 Drug Metabolism 57 Successfully Completes Phase 57 Chemotherapeutic Agents 57 Murine Model 57 Eye Diseases 57 Investigational Agent 57 J Neurosci 57 R roscovitine 57 Dose Ranging 57 Am J Obstet 57 Endocrine Society #st 57 Diagnostic Tests 57 Mayo Clin Proc 57 Receives Orphan Drug 57 Cannabinoid 57 Molecular Therapeutics 57 Pamela Espeland Published 57 Symposium SABCS 57 Reception Thurs 57 AAG geldanamycin analog 57 Intravenous Immunoglobulin 57 BY Cliff Kuang 57 • kdonica@thetowntalk.com • 57 Cutaneous T 57 Genotypes 57 Ann Pharmacother 57 Segregated Facilities Feb 57 BY Jenara Nerenberg 57 Cell Physiol 57 Estrogen Receptor 57 Cytochrome P# 57 Insulin Resistance 57 Metabolic Disease 57 Blood Cancers 57 MET VEGFR2 57 Hepatitis C Virus 57 Giselle Bautista 57 J Immunol 57 J Psychosom Res 57 Blurrz » 57 Hematological Cancers 57 Phase 2b Study 57 Relapsed Refractory 57 Cancers Symposium 57 Safinamide 57 Kidney Transplant Recipients 57 Patients Suffering 57 By CNSYD 57 ACR ARHP 57 Sapacitabine 57 Sharon Schmickle Published 57 Orthostatic Hypotension 57 #:# -# [002] 57 Molecular Therapy 57 Prognostic Factors 57 Randomized Phase II 57 EMBARGOED UNTIL 57 Int J Geriatr Psychiatry 57 Therapeutic Agents 57 Devilish Angel 57 Ed Huyck Published 57 ASGCT 57 Vertebral Fractures 57 J Periodontol 57 Therapeutic Efficacy 57 Submits Response 57 Myeloma Patients 57 WEDNESDAY FEB 57 Premature Infants 57 Investigational Treatment 57 • ifarguheson@muncie.gannett.com • 57 siRNA Delivery 57 Anti CD# Antibody 57 Targeted Therapy 57 Biomarker Discovery 57 Carotid Stenting 57 Molecular Pathogenesis 57 Postgraduate Course 57 Nanostructured Materials 57 ALLSCHWIL BASEL SWITZERLAND 57 Randomized Clinical Trial 57 Newly Diagnosed Breast Cancer 57 Aflibercept 57 HOLD FOR RELEASE 57 Stent Placement 57 NOTE EFFECTIVE 57 J Pathol 57 ASCO Gastrointestinal Cancers Symposium 57 By DOROTHY SCHNEIDER 57 Clinical Virology 57 Related Viruses 57 ASMS Conference 57 Cell Biol 57 Mol Med 57 Unfractionated Heparin 57 J Cereb Blood 57 Robbie Daw 57 Iron Overload 57 Neuroendocrinology 57 th Interscience Conference 57 Antimicrobial Activity 57 • tzulewski@thespectrum.com • 57 EASL 57 Anesth Analg 57 iSBTc 57 Protease Inhibitors 57 Gynecologic Cancer Society 57 Cancer J Clin 57 CHICO COMMUNITY BAND 57 Schizophrenia Bulletin 57 Initiates Phase III 57 ASA CSSA SSSA 57 AUA Annual Meeting 57 By Julian Prokaza 57 DNA Methylation 57 #:#-# [028] 57 Psychol Med 57 Antiviral Agents 57 Distinguished Researcher 57 Antibody Therapeutics 57 Molecular Cancer 57 Advanced Melanoma 57 prucalopride 57 Eur J Endocrinol 57 Seibertron » 57 Webcast Discussion 57 FDA Approvals 57 Hepatitis C Treatment 57 GREAT BOOKS 57 Innovative Approaches 57 BY JENNIFER BARRIOS 57 By Annemarie Mannion 57 Hyperlipidemia 57 ANNUAL MEETING 57 Hedgehog Pathway Inhibitor 57 suppl #S 57 Brain Stimulation 57 Primary Immunodeficiencies 57 Antiplatelet Therapy 57 Treatment Reduces 57 Cancer Treatments 57 HPV Vaccines 57 Therapeutic Antibodies 57 Oral Insulin 57 Initiates Enrollment 57 Nucleic Acids 57 Patent Covering 57 Hospital Acquired Pneumonia 57 Drugs Affecting Lipid 57 Is Well Tolerated 57 Article PubMed ChemPort 57 Hypercholesterolemia 57 Improves Outcomes 57 Protein Structure 57 Clinical Oncology Annual Meeting 57 Am J Cardiol 57 International Myeloma Workshop 57 MIKE MORRIS 57 UMKC CONSERVATORY 57 Antibody Discovery 57 Contrast Agents 57 Hazardous Drugs 57 FIND THIS STUDY 57 Kady O'Malley Email 57 Thurs. Fri 57 • lpowers@rgj.com • 57 AVI BioPharma Announces 57 By WALTER MENYA 57 Overactive Bladder OAB 57 Nutr 57 Brentuximab Vedotin SGN 57 Prognostic Significance 57 Josh Kalven 57 Neurobiol 57 Theriogenology 57 Pivotal Clinical Trial 57 Syndr 57 Receptor Antagonist 57 Reprod 57 AAN Annual Meeting 57 Chronic Lymphocytic Leukemia CLL 57 Opportunistic Infections CROI 57 #.#-#.# hrs 57 Gastrointestinal Oncology 57 Pharmacological 57 Novel Compound 57 doi #.#/fj.#-# 57 Susceptibility Testing 57 AHA Scientific Sessions 57 Christina Radish Posted 57 Psychosom Med 57 Localized Prostate Cancer 57 Teva Provides Update 57 Neuromuscular Diseases 57 #:#-# [016] 57 Test Detects 57 Int J Clin Pract 57 Oncogene 57 ASTRO Annual Meeting 57 Heart Failure Patients 57 Cognitive Deficits 57 #.#/journal.pmed.# 57 Mike Washlesky #:# [002] 57 Smallpox Vaccine 57 Clin Trials 57 Prognostic Value 57 Crowbar Ybor City 57 Red Hat alert RHSA 57 Neuroprotection 57 Biologia 57 Phase 2a Study 57 AMES Contact 57 Controlled Clinical Trials 57 ST Segment Elevation 57 Immunosuppression 57 Slows Progression 57 Signaling Pathways 57 Controlled Release 57 Schizophr Res 57 CYP#A# CYP#D# 57 Antiviral Research 57 Files Investigational 57 Conjugates 57 Solid Malignancies 57 UPST 57 Breast Cancer Recurrence 57 • whodkiew@greenbaypressgazette.com • 57 EUROGIN